Compare Amylx Pharmaceuticals Inc (AMLX) vs Under Armour Inc Class A (UA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amylx Pharmaceuticals Inc vs Under Armour Inc Class A — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Under Armour Inc Class A trades at $5.24 (market cap $2.26B). The key difference: Amylx Pharmaceuticals Inc is the larger of the two by market cap, and Amylx Pharmaceuticals Inc is trading nearer its 52-week high, Under Armour Inc Class A nearer its low. Which is the better fit depends on your goals.
| AMLX | UA | |
|---|---|---|
Market Cap | $2.64B | $2.26B |
Sector | Health | Consumer Cyclical |
52-Week High | $24.19 | $7.88 |
52-Week Low | $7.82 | $3.96 |
Enterprise Value | $2.39B | $3.24B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →About Under Armour Inc Class A
Under Armour is a leading inventor, marketer, and distributor of branded athletic performance apparel, footwear, and accessories. Built on the 'technical' performance of synthetic fabrics, the company is currently undergoing a multi-year brand evolution centered on premium product innovation, operational rigor, and a renewed focus on its North American core under the guidance of founder Kevin Plank.
Read more on UA →
